Abstract
We read the letter titled "Comparison of Two Anticoagulants for Pain Associated with Platelet-Rich Plasma Injections" authored by Pensato et al. in Aesthetic Plastic Surgery. The authors emphasized an important point. PRP treatments have a lot of variables; preparation method, application, amount of PRP injections, and content (such as number of platelet concentration, presence of leucocytes, and pH). However, in our study, we focused on the pain of injections. We showed that there is a pain difference by using different anticoagulants during PRP preparation, but we did not investigate for possible reason of this pain difference. The use of different anticoagulants may have caused changes in the content, and these alterations could be responsible for the variation in pain. Researches could be done to investigate the reason and the physiology of this effect.
Level of Evidence V This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.
This is a preview of subscription content, log in via an institution to check access.
References
Pensato R, Al-Amer R, La Padula S (2023) Comparison of two anticoagulants for pain associated with platelet-rich plasma injections. Aesthet Plast Surg. https://doi.org/10.1007/s00266-023-03481-1
Görgü M, Gökkaya A, Doğan A (2020) Comparison of two anticoagulants for pain associated with platelet-rich plasma injections. Aesthet Plast Surg 44(3):955–961. https://doi.org/10.1007/s00266-019-01541-z. (Epub 2019 Nov 13 PMID: 31722064)
Görgü M, Gökkaya A, Karanfil E (2021) What is the adequate PRP dose for an effective treatment? an in vitro experimental study on the skin. Aesthet Surg J 41(7):887–901. https://doi.org/10.1093/asj/sjab043. (PMID: 33493280)
Dohan Ehrenfest DM, Rasmusson L, Albrektsson T (2009) Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF). Trends Biotechnol 27(3):158–167. https://doi.org/10.1016/j.tibtech.2008.11.009. (Epub 2009 Jan 31 PMID: 19187989)
Russell RP, Apostolakos J, Hirose T et al (2013) Variability of platelet-rich plasma preparations. Sports Med Arthrosc Rev 21:186–190
Franco D, Franco T, Schettino AM et al (2012) Protocol for obtaining platelet-rich plasma (PRP), platelet-poor plasma (PPP), and thrombin for autologous use. Aesthet Plast Surg 36:1254–1259
Araki J, Jona M, Eto H et al (2012) Optimized preparation method of platelet-concentrated plasma and noncoagulating platelet-derived factor concentrates: maximization of platelet concentration and removal of fibrinogen. Tissue Eng Part C Methods 18:176–185
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflicts of interest to disclose.
Ethical Approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Informed Consent
For this type of study, informed consent is not required.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Karanfil, E., Doğan, A. & Görgü, M. Reply: Comparison of Two Anticoagulants for Pain Associated with Platelet-Rich Plasma Injections. Aesth Plast Surg (2023). https://doi.org/10.1007/s00266-023-03652-0
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00266-023-03652-0